UBS Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.73M | Buy |
1,916,704
+1,152,550
| +151% | +$3.69M | ﹤0.01% | 3763 |
|
|
2025
Q4 | $2.09M | Sell |
764,154
-172,350
| -18% | -$399K | ﹤0.01% | 4942 |
|
|
2025
Q3 | $2.03M | Sell |
936,504
-842,908
| -47% | -$1.99M | ﹤0.01% | 4937 |
|
|
2025
Q2 | $3.06M | Sell |
1,779,412
-717,337
| -29% | -$1.78M | ﹤0.01% | 4374 |
|
|
2025
Q1 | $8.31M | Sell |
2,496,749
-207,720
| -8% | -$1.07M | ﹤0.01% | 3245 |
|
|
2024
Q4 | $20M | Buy |
2,704,469
+2,082,340
| +335% | +$19.3M | ﹤0.01% | 2324 |
|
|
2024
Q3 | $5.84M | Sell |
622,129
-173,075
| -22% | -$1.64M | ﹤0.01% | 2918 |
|
|
2024
Q2 | $6.38M | Buy |
795,204
+104,324
| +15% | +$1.12M | ﹤0.01% | 2622 |
|
|
2024
Q1 | $10.2M | Sell |
690,880
-166,428
| -19% | -$1.94M | ﹤0.01% | 2252 |
|
|
2023
Q4 | $6.97M | Buy |
857,308
+615,920
| +255% | +$3.22M | ﹤0.01% | 2419 |
|
|
2023
Q3 | $1.1M | Sell |
241,388
-228,424
| -49% | -$1.49M | ﹤0.01% | 3982 |
|
|
2023
Q2 | $3.31M | Buy |
469,812
+42,993
| +10% | +$308K | ﹤0.01% | 3003 |
|
|
2023
Q1 | $2.61M | Sell |
426,819
-370,863
| -46% | -$2.56M | ﹤0.01% | 3153 |
|
|
2022
Q4 | $5.1M | Buy |
797,682
+691,443
| +651% | +$5.4M | ﹤0.01% | 2489 |
|
|
2022
Q3 | $1.02M | Buy |
106,239
+11,600
| +12% | +$134K | ﹤0.01% | 3742 |
|
|
2022
Q2 | $1.04M | Sell |
94,639
-265,107
| -74% | -$3.47M | ﹤0.01% | 3704 |
|
|
2022
Q1 | $5.99M | Buy |
359,746
+140,209
| +64% | +$2.17M | ﹤0.01% | 2363 |
|
|
2021
Q4 | $4.19M | Buy |
219,537
+23,253
| +12% | +$512K | ﹤0.01% | 3013 |
|
|
2021
Q3 | $4.84M | Buy |
196,284
+133,742
| +214% | +$3.15M | ﹤0.01% | 2707 |
|
|
2021
Q2 | $1.63M | Sell |
62,542
-35,306
| -36% | -$918K | ﹤0.01% | 3758 |
|
|
2021
Q1 | $3.1M | Buy |
97,848
+12,219
| +14% | +$506K | ﹤0.01% | 3103 |
|
|
2020
Q4 | $3.97M | Buy |
85,629
+13,650
| +19% | +$542K | ﹤0.01% | 2700 |
|
|
2020
Q3 | $2.37M | Buy |
71,979
+26,685
| +59% | +$818K | ﹤0.01% | 2892 |
|
|
2020
Q2 | $1.24M | Buy |
45,294
+17,495
| +63% | +$575K | ﹤0.01% | 3317 |
|
|
2020
Q1 | $832K | Sell |
27,799
-112,893
| -80% | -$2.99M | ﹤0.01% | 3510 |
|
|
2019
Q4 | $3.89M | Sell |
140,692
-235,229
| -63% | -$5.35M | ﹤0.01% | 2851 |
|
|
2019
Q3 | $6.84M | Buy |
375,921
+244,162
| +185% | +$5.4M | ﹤0.01% | 2090 |
|
|
2019
Q2 | $3.23M | Buy |
131,759
+121,504
| +1,185% | +$1.83M | ﹤0.01% | 2707 |
|
|
2019
Q1 | $98K | Sell |
10,255
-259,239
| -96% | -$2.52M | ﹤0.01% | 5085 |
|
|
2018
Q4 | $2.38M | Buy |
269,494
+223,833
| +490% | +$2.16M | ﹤0.01% | 2862 |
|
|
2018
Q3 | $513K | Buy |
45,661
+38,276
| +518% | +$543K | ﹤0.01% | 4378 |
|
|
2018
Q2 | $95K | Sell |
7,385
-53,837
| -88% | -$787K | ﹤0.01% | 5480 |
|
|
2018
Q1 | $1.03M | Buy |
61,222
+59,826
| +4,286% | +$906K | ﹤0.01% | 3676 |
|
|
2017
Q4 | $11K | Sell |
1,396
-6,604
| -83% | -$53K | ﹤0.01% | 6956 |
|
|
2017
Q3 | $62K | Sell |
8,000
-1,072
| -12% | -$6.78K | ﹤0.01% | 5641 |
|
|
2017
Q2 | $67K | Sell |
9,072
-15,928
| -64% | -$101K | ﹤0.01% | 5451 |
|
|
2017
Q1 | $186K | Sell |
25,000
-137,770
| -85% | -$1.01M | ﹤0.01% | 4689 |
|
|
2016
Q4 | $1.13M | Sell |
162,770
-130,238
| -44% | -$896K | ﹤0.01% | 3442 |
|
|
2016
Q3 | $2.41M | Buy |
293,008
+14,302
| +5% | +$121K | ﹤0.01% | 2674 |
|
|
2016
Q2 | $2.26M | Buy |
278,706
+1,991
| +0.7% | +$12.5K | ﹤0.01% | 2675 |
|
|
2016
Q1 | $1.41M | Sell |
276,715
-24,604
| -8% | -$135K | ﹤0.01% | 2982 |
|
|
2015
Q4 | $2.33M | Sell |
301,319
-56,681
| -16% | -$393K | ﹤0.01% | 2656 |
|
|
2015
Q3 | $2.06M | Buy |
358,000
+37,900
| +12% | +$295K | ﹤0.01% | 2715 |
|
|
2015
Q2 | $2.94M | Buy |
320,100
+116,600
| +57% | +$1.3M | ﹤0.01% | 2607 |
|
|
2015
Q1 | $2.46M | Buy |
+203,500
| New | +$2.29M | ﹤0.01% | 2740 |
|
Other funds holding IOVA
MFM
VCM
VPM
ICM